State of New Jersey Common Pension Fund D Has $7.05 Million Stake in Centene Corporation $CNC

State of New Jersey Common Pension Fund D decreased its position in Centene Corporation (NYSE:CNC) by 6.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 171,232 shares of the company’s stock after selling 12,161 shares during the period. State of New Jersey Common Pension Fund D’s holdings in Centene were worth $7,046,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Addison Advisors LLC boosted its stake in Centene by 455.6% in the 3rd quarter. Addison Advisors LLC now owns 739 shares of the company’s stock worth $26,000 after purchasing an additional 606 shares during the period. Mowery & Schoenfeld Wealth Management LLC purchased a new stake in Centene in the 3rd quarter worth approximately $27,000. WPG Advisers LLC lifted its position in Centene by 44.5% in the 3rd quarter. WPG Advisers LLC now owns 915 shares of the company’s stock worth $33,000 after buying an additional 282 shares in the last quarter. Bogart Wealth LLC lifted its position in Centene by 11,011.1% in the 3rd quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock worth $36,000 after buying an additional 991 shares in the last quarter. Finally, Ameriflex Group Inc. lifted its position in Centene by 152.5% in the 3rd quarter. Ameriflex Group Inc. now owns 1,010 shares of the company’s stock worth $36,000 after buying an additional 610 shares in the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.

Centene Stock Performance

Shares of CNC opened at $53.37 on Friday. The company has a market capitalization of $26.36 billion, a PE ratio of -4.06, a price-to-earnings-growth ratio of 1.03 and a beta of 1.06. Centene Corporation has a one year low of $25.08 and a one year high of $64.15. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.12 and a quick ratio of 1.10. The company’s fifty day moving average price is $38.91 and its 200 day moving average price is $39.47.

Centene (NYSE:CNC) last announced its earnings results on Tuesday, April 28th. The company reported $3.37 EPS for the quarter, topping the consensus estimate of $2.23 by $1.14. The firm had revenue of $49.94 billion for the quarter, compared to the consensus estimate of $47.53 billion. Centene had a negative net margin of 3.25% and a positive return on equity of 5.57%. The business’s quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the firm posted $2.90 EPS. As a group, analysts expect that Centene Corporation will post 3.46 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have issued reports on CNC. Wall Street Zen upgraded shares of Centene from a “hold” rating to a “buy” rating in a research report on Saturday. UBS Group increased their target price on shares of Centene from $42.00 to $55.00 and gave the stock a “neutral” rating in a research report on Wednesday. Deutsche Bank Aktiengesellschaft raised their price target on shares of Centene from $39.00 to $53.00 and gave the company a “hold” rating in a report on Wednesday. Wells Fargo & Company raised their price target on shares of Centene from $44.00 to $56.00 and gave the company an “equal weight” rating in a report on Friday. Finally, Oppenheimer restated an “outperform” rating and set a $58.00 price target (up from $45.00) on shares of Centene in a report on Wednesday. Six investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, Centene presently has a consensus rating of “Hold” and an average price target of $52.12.

Key Stories Impacting Centene

Here are the key news stories impacting Centene this week:

• Positive Sentiment: Q1 results beat expectations: Centene reported stronger-than-expected EPS and raised its outlook, which supports margin improvement narratives that helped multiple brokers upgrade or re-assess the name. Read More.
• Positive Sentiment: Wall Street bullish notes: Truist reiterated a Buy rating and Cantor Fitzgerald upgraded the stock, signaling investor confidence from some major brokers. Read More. Read More.
• Positive Sentiment: Longer-term recovery thesis boosted: A Seeking Alpha piece highlights promising 2027 turnaround prospects and potential momentum reversal—supportive for investors focused on multi‑year recovery. Read More.
• Positive Sentiment: Wells Fargo raised its price target to $56 while keeping an Equal Weight view, indicating some upside in the broker community even as conviction is measured. Read More.
• Neutral Sentiment: Broker PTs raised but ratings cautious: Deutsche Bank, Mizuho and Morgan Stanley all lifted targets (to $53, $50 and $50 respectively) but maintained Hold/Neutral/Equal Weight stances — a modest vote of confidence that stops short of strong endorsement. Read More. Read More. Read More.
• Neutral Sentiment: Analysts’ opinions remain mixed overall — coverage notes a blend of upgrades and cautious takes, keeping sentiment balanced rather than uniformly positive. Read More.
• Negative Sentiment: Lower consensus price target: A brokerage consensus report shows a $42 average target — well below current levels — which could cap upside if that view gains traction. Read More.
• Negative Sentiment: Execution concerns flagged: A Seeking Alpha commentary warns that further upside will require better operational execution, a caution investors may lean on after recent volatility. Read More.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.